Agenus Inc (AGEN) Company Long-Term Loans and Borrowings

Agenus, Inc. - graphic logo of issuer AGEN

Agenus (AGEN) is a recognized expert in immuno-oncology, developing cutting-edge methods to stimulate the body's defenses against tumors. Business stability relies on the success of new colorectal cancer therapy regimens and the ability to monetize intellectual property. The current metric is 0.00. Serving as a valuation tool, this price chart clearly demonstrates financial dynamics amid the completion of large-scale clinical trials for drugs treating solid tumors.

AGEN Agenus: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for Agenus Inc (AGEN)

- price and consensus price forecast:
Stock Price agenusbio.com|AGEN - Price Target Chart
- market capitalization data:
Market Value Agenus|AGEN - Total Company Value
- book capitalization data:
Accounting Value per Share Agenus|AGEN - Book Capitalization|Market Capitalization to Book Value Ratio agenusbio.com|AGEN - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Agenus|AGEN - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Agenus, Inc|AGEN - Company Debts|Debt to Book Value Agenus|AGEN - Company Long-Term Debt|Company Current Liabilities Agenus
Fundamental company valuation:agenusbio.com (AGEN)
Original product of Agenus

Long-term debt reflects the total volume of obligations with a maturity exceeding one year, determining the issuer's financial stability and credit profile. By analyzing the size of a business's long-term borrowed capital, investors assess the balance between debt load and future capitalization potential. The dynamics of this metric are driven by the issuance of bonds and long-term credit lines to finance operating activities. For Agenus (AGEN), this confirms the impossibility of expansion through acquisitions, shifting the development strategy toward organic growth and strategic partnerships.

Competitor analysis for Agenus

argenx.com - Company Long-Term Debts|Company Long-Term Debt BioNTech (BNTX)|ABVX: Company Long-Term Loans and Borrowings|ADMA (ADMA Bio) - Company Long-Term Debt|Protagonist Corp (PTGX) - Company Long-Term Liabilities|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com (KNSA)|Grifols (GRFS) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Adaptive Biotech (ADPT)|Company Long-Term Debts CLDX|Aurinia Corp - Long-Term Debt Volume|BCRX: Company Long-Term Debt|VERA: Company Long-Term Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Long-Term Liabilities|Company Long-Term Debts TRML|Company Long-Term Debt Precigen, Inc. PGEN|Company Long-Term Indebtedness pharming.com (PHAR)|NKTR: Company Long-Term Debts|Long-Term Debt Upstream Bio, Inc. UPB|Zenas Biopharma, Inc. - Company Long-Term Debts|IMNM - Company Long-Term Debts|Company Long-Term Debts GOSS (Gossamer Bio, Inc.)|kalvista.com (KALV) - Long-Term Indebtedness|Company Long-Term Debts SEPN (Septerna)|Long-Term Debt PVLA|Company Long-Term Debt Savara Corp SVRA|Company Long-Term Indebtedness Rigel Corp RIGL|Company Long-Term Liabilities ANAB (AnaptysBio, Inc.)|astriatx.com - Company Long-Term Debts|Company Long-Term Debt ENGN (enGene)|RAPT - Long-Term Debt Volume|JBIO: Company Long-Term Debts|Aclaris Therapeutics, Inc (ACRS) - Company Long-Term Debts|Kyverna Therapeutics - Company Long-Term Debts|Long-Term Indebtedness tizianalifesciences.com|Cabaletta Bio - Company Long-Term Debts|Long-Term Debt VTYX (Ventyx Biosciences Inc.)|THTX - Company Long-Term Debt|Avalo Therapeutics Inc - Company Long-Term Indebtedness|Company Long-Term Debt Eledon Pharmaceuticals|CLYM - Long-Term Liabilities|Company Long-Term Debts Zura Bio Limited ZURA|aTyr Pharma Inc (ATYR) - Company Long-Term Loans and Borrowings|ADAG (Adagene Inc) - Company Long-Term Debts|Company Long-Term Debts IMA|Shattuck Labs, Inc. (STTK) - Company Long-Term Debt|Company Long-Term Loans and Borrowings EQ (equilliumbio.com)|Connect Biopharma Holdings Limited - Company Long-Term Debt|Company Long-Term Liabilities Immunic Therapeutics IMUX|Atara Biotherapeutics Inc - Company Long-Term Debts|InflaRx N.V. (IFRX) - Company Long-Term Debts|Company Long-Term Liabilities X4 Pharmaceuticals XFOR|Adicet Bio, Inc. (ACET) - Company Long-Term Loans and Borrowings|CELU: Company Long-Term Debts|Long-Term Debt Volume INMB|Company Long-Term Debt BRNS (Barinthus Bio)|Company Long-Term Liabilities KZR (Kezar Life Sciences Inc)|SAB Biotherapeutics - Company Long-Term Debt|AKTX - Company Long-Term Liabilities|Enlivex Therapeutics, Ltd. - Company Long-Term Liabilities|QTTB: Company Long-Term Debts|Company Long-Term Debt GeoVax Labs Inc|Edesa Biotech Corp (EDSA) - Company Long-Term Indebtedness|Company Long-Term Debts IBIO (iBio, Inc.)|Long-Term Debt Carisma Tx|Company Long-Term Debts XTLB|Company Long-Term Debts boltbio.com (BOLT)|HCWB (HCW Biologics) - Company Long-Term Debts|Long-Term Indebtedness Aptevo Therapeutics, Inc. APVO|AIM (AIM ImmunoTech) - Company Long-Term Debts|ADTX: Long-Term Debt|Company Long-Term Debt GRI Bio|Company Long-Term Indebtedness XORTX Therapeutics Inc|HIND (ReShape Lifesciences) - Company Long-Term Liabilities|Company Long-Term Debts REVB|INDP (Indaptus Therapeutics) - Company Long-Term Debt|Long-Term Debt Volume scinai.com (SCNI)|Company Long-Term Debts CALI (CalciMedica)|Company Long-Term Debts Affimed NV AFMD|Company Long-Term Debts ALLK|HOOK - Long-Term Indebtedness|Company Long-Term Debts IGMS|ITOS (iteostherapeutics.com) - Long-Term Debt|Company Long-Term Debt Ocean Biomedical (OCEA)|Company Long-Term Indebtedness TCBP|THRD - Company Long-Term Debt